AVIR CIK: 1593899

Atea Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.0
FY22:
−121
FY23:
−85.4
FY24:
−135
FY25:
−132
Change from FY21 to FY25
millions USD
FY21:
0.00
FY22:
−455
FY23:
40.3
FY24:
56.1
FY25:
189
Change from FY21 to FY25
millions USD
FY21:
1.47
FY22:
0.37
FY23:
0.26
FY24:
0.27
FY25:
−25.7
millions USD
FY21:
−85.5
FY22:
−576
FY23:
−44.8
FY24:
−79.1
FY25:
31.0
(positive)
Change from FY21 to FY22
millions USD
FY21:
−87.0
FY22:
−123
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR